
Naveris
NAVERIS: Innovating technology for transformative cancer detection and drug development.
- 67
- Company
- Waltham, MA, USUnited States
Naveris, founded with a mission to revolutionize cancer detection and treatment, focuses on developing advanced technologies for early cancer identification. The company offers highly sensitive blood tests and liquid biopsies designed to detect viral cancers at their earliest stages. Naveris aims to improve patient outcomes by transforming how cancers are detected, facilitating timely interventions, and enhancing drug development and clinical trials.
Notable figures affiliated with Naveris include experts in oncology and biotechnology, contributing to the company's innovative edge. The startup has garnered attention and investment from key players in the healthcare industry, underscoring its potential impact. Naveris' significant achievements include the development of NavDx®, a groundbreaking test that has set new standards in cancer diagnostics. Through its pioneering efforts, Naveris is making substantial strides in improving early cancer detection and patient care.
Similar Companies

Micronoma
micronoma.com

Pharus Diagnostics
pharusdx.com

Harbinger Health

Early Detection
cancer.us

Mercy BioAnalytics
mercybio.com

Oncodea
oncodea.com

Acuamark Diagnostics
acuamarkdx.com

Harae Dx
haraedx.com

Earli
earli.com

Droplet Biosciences
dropletbiosci.com

Lucence
lucence.com

Helio Health
heliohealth.com

Grail
grail.com

Torpedo Diagnostics

X-Zell
x-zell.com
Cirina
cirina.com
NanoVision Diagnostics

NovaScan
novascaninc.com

AOA Dx
aoadx.com

AEENA Dx
aeenadx.com
Quick Facts
Who are Naveris' competitors?
Companies similar to Naveris include Micronoma, Pharus Diagnostics, Harbinger Health and Early Detection.
When was Naveris founded?
Naveris was founded in 2017.
Where is Naveris' headquarters located?
Naveris' headquarters is located in Waltham, MA, US.
When was Naveris' last funding round?
Naveris' most recent funding round was for $33.4M (USD) in September 2022.
How much disclosed funding has Naveris raised?
As of Sep 19, 2022, Naveris has disclosed funding of $48.8M (USD). Undisclosed round amounts are excluded.
How many employees does Naveris have?
Naveris has 67 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Model
- Customer
- Main Product
- Also Known As
- Naveris Inc.
- Headquarters
- 35 Gatehouse Drive
- Waltham, MA, 02451
- US
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified